Metabomed
Drug discovery company in the field of cancer metabolism
Metabomed has raised €16M across 1 funding round from 5 investors, most recently a Series A round in Apr 2016. Based in Yavne, Israel; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€16M
€15,810,277
Funding rounds
1
Investors
5
distinct backers
Active since
2016-04
latest 2016-04
Funding by year
EUR raised per yearMetabomed — funding by year — interactive chart.
Data table
| Metabomed — funding by year | |
|---|---|
| 2016 | €16M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-04-01 | Series A | €16M | Arkin Holdings,Boehringer Ingelheim Venture Fund,MS Ventures,Pfizer Ventures,Pontifax Funds | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData